Convergence of diagnostics & therapeutics is steadily redefining standard care pathways: Dr Anand K: Nandita Vijayasimha, Bengaluru Tuesday, January 20, 2026, 08:00 Hrs [IST] The ...
The transition from conventional microscopy to whole-slide imaging and digital platforms is reshaping pathology practices.
According to Adalyon’s CEO, Ulrik Zeuthen, speech-based biomarkers can be used across several applications to optimise trial ...
Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.
Making is Fueling Strong Growth in Pan-Genomic and Multi-Gene Panel Testing, Supported by Expanding NGS Access, Advanced ...
Enterprises are moving beyond AI hype toward measurable value. Here's how semantics, vertical AI and outcome-driven agents ...
According to Mordor Intelligence, the digital pathology market is valued at USD 2.01 billion in 2026, and is projected to surpass USD 3.2 billion ...
Designed to replace the legacy FieldMate and FieldMaxII platforms, the new meters feature a modern 5-inch color touchscreen, ...
The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...
Saudi Arabia is already operating the kind of connected, AI-enabled healthcare infrastructure many countries are still ...
From pre-dawn toddler wake-up calls to board prep, model diagnostics and late-night electric-cello sessions, Pierre du Toit, ...
RetinalGenix is developing a portfolio of non‑invasive imaging solutions, including a portable Retinal Imaging Screening Device and the RetinalCam remote monitoring system, designed for use without ...